Grants for Biotech Companies in Massachusetts (2026)
Massachusetts is the densest biotech market in the world by company count per capita, with Kendall Square, the Longwood Medical Area, the Seaport, and Waltham anchoring a research ecosystem that includes MIT, Harvard, BWH, MGH, Dana-Farber, Boston Children's, and Broad Institute. For bootstrapped Massachusetts biotech founders, non-dilutive capital stacks federal NIH SBIR/STTR and BARDA programs with exceptionally strong state-level programs from the Massachusetts Life Sciences Center (MLSC) — Small Business Matching Grants that double federal SBIR funding for qualifying MA companies are a distinctive state advantage. LabCentral's community and partner programs add lab infrastructure and mentorship. The Engine (MIT-founded) supports tough tech biotech with patient capital. MassChallenge HealthTech is zero-equity. Harvard and MIT technology licensing offices fund spin-outs. BIO Ventures for Global Health and Partners HealthCare Innovation add disease-specific and clinical translation pathways. Bootstrap Directory aggregates Massachusetts biotech grants across federal, state, and private sources for efficient prioritization. The combination of MLSC matching grants with NIH SBIR Phase II awards represents one of the strongest state-level biotech non-dilutive stacks available anywhere in the U.S.
Frequently Asked Questions
What does MLSC offer biotech founders?
The Massachusetts Life Sciences Center operates Small Business Matching Grants (that stack on federal SBIR/STTR awards to effectively double non-dilutive funding for MA companies), the Internship Challenge, workforce grants, and capital programs. It's one of the best-funded state-level life sciences programs in the world and is a core part of the MA biotech non-dilutive stack.
What is LabCentral?
LabCentral is a shared biotech lab facility in Kendall Square providing rentable lab bench space, equipment, and community for early-stage biotech founders. It's not a direct grant-maker but its partner programs (with pharma sponsors, MLSC, and foundations) route non-dilutive support to member companies, particularly early-stage Massachusetts biotechs.
When are Massachusetts biotech grant deadlines?
NIH SBIR solicitations open 3x annually. MLSC programs have their own application windows (often annual or biannual). BARDA, CDMRP operate on agency cycles. MassChallenge HealthTech has two cohorts annually. Bootstrap Directory tracks current Massachusetts biotech openings across all programs.